Evidence of SARS-CoV-2 convergent evolution in immunosuppressed patients treated with antiviral therapies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Evidence of SARS-CoV-2 convergent evolution in immunosuppressed patients treated with antiviral therapies ; volume:21 ; number:1 ; day:7 ; month:5 ; year:2024 ; pages:1-13 ; date:12.2024
Virology journal ; 21, Heft 1 (7.5.2024), 1-13, 12.2024
- Urheber
-
Feng, Shuchen
Reid, Gail E.
Clark, Nina M.
Harrington, Amanda
Uprichard, Susan L.
Baker, Susan C.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12985-024-02378-y
- URN
-
urn:nbn:de:101:1-2407180815272.277181247811
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Feng, Shuchen
- Reid, Gail E.
- Clark, Nina M.
- Harrington, Amanda
- Uprichard, Susan L.
- Baker, Susan C.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Convergent evolution of SARS-CoV-2 in human and animals
Lack of antiviral activity of darunavir against SARS-CoV-2
SARS-CoV-2 RNA polymerase as target for antiviral therapy
Immunoliposomes As a Promising Antiviral Agent against SARS-CoV-2
Potential antiviral peptides targeting the SARS-CoV-2 spike protein
Body temperature-controlled antiviral response and SARS-CoV-2 replication
Antiviral molecules for the intervention of SARS-CoV-2 infections
SARS‐CoV‐2–host proteome interactions for antiviral drug discovery
Antiviral effect of cetylpyridinium chloride in mouthwash on SARS-CoV-2
The molecular mechanism of SARS-CoV-2 evading host antiviral innate immunity
Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
Antiviral efficacy of heparan sulfate and enoxaparin sodium against SARS‐CoV‐2
Convergent evolution of SARS-CoV-2 in human and animals
Lack of antiviral activity of darunavir against SARS-CoV-2
SARS-CoV-2 RNA polymerase as target for antiviral therapy
Immunoliposomes As a Promising Antiviral Agent against SARS-CoV-2
Potential antiviral peptides targeting the SARS-CoV-2 spike protein
Body temperature-controlled antiviral response and SARS-CoV-2 replication
Antiviral molecules for the intervention of SARS-CoV-2 infections
SARS‐CoV‐2–host proteome interactions for antiviral drug discovery
Antiviral effect of cetylpyridinium chloride in mouthwash on SARS-CoV-2
The molecular mechanism of SARS-CoV-2 evading host antiviral innate immunity
Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
Antiviral efficacy of heparan sulfate and enoxaparin sodium against SARS‐CoV‐2
Convergent evolution of SARS-CoV-2 in human and animals
Lack of antiviral activity of darunavir against SARS-CoV-2
SARS-CoV-2 RNA polymerase as target for antiviral therapy
Immunoliposomes As a Promising Antiviral Agent against SARS-CoV-2
Potential antiviral peptides targeting the SARS-CoV-2 spike protein
Body temperature-controlled antiviral response and SARS-CoV-2 replication
Antiviral molecules for the intervention of SARS-CoV-2 infections
SARS‐CoV‐2–host proteome interactions for antiviral drug discovery
Antiviral effect of cetylpyridinium chloride in mouthwash on SARS-CoV-2
The molecular mechanism of SARS-CoV-2 evading host antiviral innate immunity
Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants